Lack of correlation between O-serotype, bacteriophage susceptibility and genomovar status in the Burkholderia cepacia complex

被引:14
作者
Kenna, DT
Barcus, VA
Langley, RJ
Vandamme, P
Govan, JRW
机构
[1] Univ Edinburgh, Sch Med, Cyst Fibrosis Lab, Edinburgh EH8 9AG, Midlothian, Scotland
[2] Univ Ghent, Mikrobiol Lab, B-9000 Ghent, Belgium
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2003年 / 35卷 / 02期
关键词
Burkholderia cepacia complex; cystic fibrosis; lipopolysaccharide; serotypes; bacteriophage;
D O I
10.1016/S0928-8244(02)00442-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Burkholderia cepacia complex comprises at least nine phylogenetically related genomic species (genomovars) which clause life-threatening infection in immunocompromised humans, particularly individuals. with cystic fibrosis or chronic granulomatous disease. Prior to recognition that 'B cepacia' comprise multiple species, in vitro studies revealed that the lipopolysaccharide (LPS) of these Gram-negative bacteria is strongly endotoxic. In this study, we used 117 B. cepacia complex isolates to determine if there is a correlation between O-antigen serotype and genomovar status. Isolates were also tested for their ability to act as bacterial hosts for the LPS-binding bacteriophages NS1 and NS2. The absence of genomovar 11 (Burkholderia multivorans) in 'historical R cepacia' isolates was notable. Neither O-serotype nor phage susceptibility correlated with genomovar status. We conclude that variability in LPS may contribute to the success of these highly adaptable bacteria as human pathogens. (C) 2002 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:87 / 92
页数:6
相关论文
共 46 条
[31]   ROLE OF THE RFAG AND RFAP GENES IN DETERMINING THE LIPOPOLYSACCHARIDE CORE STRUCTURE AND CELL-SURFACE PROPERTIES OF ESCHERICHIA-COLI K-12 [J].
PARKER, CT ;
KLOSER, AW ;
SCHNAITMAN, CA ;
STEIN, MA ;
GOTTESMAN, S ;
GIBSON, BW .
JOURNAL OF BACTERIOLOGY, 1992, 174 (08) :2525-2538
[32]   Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland [J].
Pitt, TL ;
Kaufmann, ME ;
Patel, PS ;
Benge, LCA ;
Gaskin, S ;
Livermore, DM .
JOURNAL OF MEDICAL MICROBIOLOGY, 1996, 44 (03) :203-210
[33]  
RABKIN CS, 1989, REV INFECT DIS, V11, P600
[34]   Genetic variation at the O-antigen biosynthetic locus in Pseudomonas aeruginosa [J].
Raymond, CK ;
Sims, EH ;
Kas, A ;
Spencer, DH ;
Kutyavin, TV ;
Ivey, RG ;
Zhou, Y ;
Kaul, R ;
Clendenning, JB ;
Olson, MV .
JOURNAL OF BACTERIOLOGY, 2002, 184 (13) :3614-3622
[35]  
RICHARD C, 1981, ANN BIOL CLIN-PARIS, V39, P9
[36]   THE CHEMICAL-STRUCTURE OF BACTERIAL-ENDOTOXIN IN RELATION TO BIOACTIVITY [J].
RIETSCHEL, ET ;
KIRIKAE, T ;
SCHADE, FU ;
ULMER, AJ ;
HOLST, O ;
BRADE, H ;
SCHMIDT, G ;
MAMAT, U ;
GRIMMECKE, HD ;
KUSUMOTO, S ;
ZAHRINGER, U .
IMMUNOBIOLOGY, 1993, 187 (3-5) :169-190
[37]  
SCHAFER A, 1991, FEMS MICROBIOL LETT, V78, P69, DOI [10.1016/0378-1097(91)90257-B, 10.1016/S0378-1097(99)00347-X]
[38]   BIOLOGICAL-ACTIVITY OF BURKHOLDERIA (PSEUDOMONAS) CEPACIA LIPOPOLYSACCHARIDE [J].
SHAW, D ;
POXTON, IR ;
GOVAN, JRW .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1995, 11 (02) :99-106
[39]  
Speert DP, 2002, EMERG INFECT DIS, V8, P181
[40]   Identification of IS1356, a new insertion sequence, and its association with IS402 in epidemic strains of Burkholderia cepacia infecting cystic fibrosis patients [J].
Tyler, SD ;
Rozee, KR ;
Johnson, WM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (07) :1610-1616